Advanced in Prolymphocytic Leukemia

Dr. Adrienne A. Phillips

Hematology Oncology | Oncology | Transplant Surgery
Barnabas Health Medical Group PC
94 Old Short Hills Rd, 
Livingston, NJ 
Advanced in Prolymphocytic Leukemia
Barnabas Health Medical Group PC
94 Old Short Hills Rd, 
Livingston, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adrienne Phillips is a Hematologist Oncology specialist and an Oncologist in Livingston, New Jersey. Dr. Phillips is rated as an Advanced provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are Adult T-Cell Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 46 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Transplant Surgery
Licenses
Internal Medicine in NJ
Hospital Affiliations
Cooperman Barnabas Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

BARNABAS HEALTH MEDICAL GROUP PC
94 Old Short Hills Rd, Livingston, NJ 07039

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Enrollment Status: Active_not_recruiting
Publish Date: September 30, 2025
Intervention Type: Drug, Other, Procedure
Study Drugs: Carmustine, Cyclophosphamide, Cytarabine, Etoposide, Ibrutinib, Melphalan
Study Phase: Phase 3
Parallel Phase II Trial of IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
Parallel Phase II Trial of IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia
Enrollment Status: Terminated
Publish Date: February 13, 2024
Intervention Type: Biological
Study Drugs: Haplo-identical cells, Umbilical cord blood unit
Study Phase: Phase 2
A Pilot Study of a Novel Sequential Treatment Utilizing CPX-351 as Salvage Chemotherapy Followed by Allogeneic Stem-Cell Transplantation (SCT) Utilizing a Haplo-cord Graft for Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
A Pilot Study of a Novel Sequential Treatment Utilizing CPX-351 as Salvage Chemotherapy Followed by Allogeneic Stem-Cell Transplantation (SCT) Utilizing a Haplo-cord Graft for Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome
Enrollment Status: Completed
Publish Date: December 21, 2022
Intervention Type: Drug, Biological
Study Drugs: CPX-351, Fludarabine, Melphalan, Rabbit Anti-Human T-Lymphocyte Globulin, Haplo-Cord Stem Cell Transplantation
Study Phase: Phase 1
Epigenetic Priming With 5-Azacytidine Prior to in Vivo T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With High Risk Myeloid Malignancies in Morphologic Remission
Epigenetic Priming With 5-Azacytidine Prior to in Vivo T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With High Risk Myeloid Malignancies in Morphologic Remission
Enrollment Status: Completed
Publish Date: September 22, 2021
Intervention Type: Radiation, Drug
Study Drugs: 5-Azacytidine, Fludarabine, Melphalan, Alemtuzumab
Study Phase: Phase 2
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
A Phase 1 Dose-ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 Following Local Intratumoral, Subcutaneous, and Intravenous Administration in Subjects With Various Lymphomas and Leukemias
Enrollment Status: Completed
Publish Date: November 23, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 4 Less Clinical Trials

45 Total Publications

Nodal T-Cell Lymphoma Transdifferentiated from Mantle Cell Lymphoma with Epstein-Barr Virus Infection.
Nodal T-Cell Lymphoma Transdifferentiated from Mantle Cell Lymphoma with Epstein-Barr Virus Infection.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: June 21, 2024
Similar Doctors
Distinguished in Prolymphocytic Leukemia
Dr. Sarah C. Rutherford
Hematology Oncology | Oncology | Hematology
Distinguished in Prolymphocytic Leukemia
Dr. Sarah C. Rutherford
Hematology Oncology | Oncology | Hematology

Weill Medical College Of Cornell

520 E 70th St, 
New York, NY 
 (18.4 miles away)
646-962-2012
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Sarah Rutherford is a Hematologist Oncology specialist and an Oncologist in New York, New York. Dr. Rutherford has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Bone Marrow Aspiration, and Lymphadenectomy.

Advanced in Prolymphocytic Leukemia
Dr. Jocelyn L. Wozney
Hematology Oncology | Hematology | Oncology
Advanced in Prolymphocytic Leukemia
Dr. Jocelyn L. Wozney
Hematology Oncology | Hematology | Oncology

North Shore Health System Medical Faculty Group Practice Inc

210 E 64th St, Fl 4, 
New York, NY 
 (17.9 miles away)
212-434-4460
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jocelyn Wozney is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Wozney is rated as a Distinguished provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Familial Pancreatic Cancer, and Bone Marrow Aspiration.

Advanced in Prolymphocytic Leukemia
Dr. Jasmine M. Zain
Hematology | Oncology | Hematology Oncology
Advanced in Prolymphocytic Leukemia
Dr. Jasmine M. Zain
Hematology | Oncology | Hematology Oncology

Memorial Hematology Lymphoma Group

1275 York Ave, 
New York, NY 
 (18.3 miles away)
212-639-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jasmine Zain is a Hematologist and an Oncologist in New York, New York. Dr. Zain is rated as an Elite provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Phillips's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 48 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile